gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
J Endocrinol 2014 Nov;223(2):181-90. Epub 2014 sep 16
PMID: 25228504
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.
Blood Cancer J 2014;4():e196. Epub 2014 mar 21
PMID: 24658374
The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation.
J Bone Miner Res 2014 Jun;29(6):1492-505.
PMID: 24339143
Anti-c-MET Nanobody(®) - a new potential drug in multiple myeloma treatment.
Eur J Haematol 2013 Aug 17. Epub 2013 aug 17
PMID: 23952536
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU